B7-1 (CD80) Human Recombinant Protein
CNY 3140.00
货期*
5周
规格
Product images
推荐一起购买 (1)
CD80 mouse monoclonal antibody, clone OTI2E5 (formerly 2E5)
CNY 1999.00
CNY 2700.00
Specifications
| Product Data | |
| Species | Human |
| Protein Source | Human |
| Expression cDNA Clone or AA Sequence |
Val35-Asn242
|
| Tag | C-His |
| Buffer | Lyophilized from a 0.2 um filtered solution of PBS, pH7.4 |
| Note | Recombinant Human B7-1/CD80 is produced with our Mammalian expression system. The target protein is expressed with sequence (Val35-Asn242) of Human CD80/B7-1 fused with a 6His tag at the C-terminus. |
| Storage | Lyophilized protein should be stored at < -20°C, though stable at room temperature for 3 weeks. Reconstituted protein solution can be stored at 4-7°C for 2-5 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months. |
| Stability | 12 months from date of despatch |
| Reference Data | |
| Locus ID | 941 |
| UniProt ID | P33681 |
| Synonyms | CD80, Activation B7-1 antigen, B7, BB1, CD28LG1, CD28LGB7-1 antigen, T-lymphocyte activation antigen CD80 |
| Summary | CD80, also known as B7-1, is a member of cell surface immunoglobulin superfamily. CD80 is predominately expressed on the surface of antigen-presenting cells including activated B cells, macrophages and dendritic cells. CD80 and CD86, together with their receptors CD28 and CTLA4, form one of the dominant co-stimulatory pathways that mediate T- and B- cell responses. Although both CD28 and CTLA4 can bind to CD80 and CD86, CTLA-4 has 20-100 fold higher affinity than CD28 plays a role in the down-regulation of the immune response. CD80 is also involved in the induction of innate immune responses by activating NF-?B-signaling pathway in macrophages. Therefore, CD80 has the potential to be promising therapeutic targets for autoimmune diseases and various carcinomas. |
| Protein Families | Druggable Genome, Transcription Factors, Transmembrane |
| Protein Pathways | Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Graft-versus-host disease, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Type I diabetes mellitus, Viral myocarditis |
Documents
| FAQs |
| SDS |
Customer
Reviews
Loading...
